InvestorsHub Logo

Know-Fear

12/01/22 12:34 AM

#541174 RE: pgsd #541008

So apparently in this instance he has clarity on “economic decisions” being made by other entities …. good for him. Unfortunately the perception from the NIH “economic decision” negatively affects him. He has a lucrative niche* market with an alternative therapy for patients who can afford it and DCVax-L is a threat. Am I missing anything?

* Created by the lack of NIH funding.